• Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

  • Feb 11 2021
  • Durée: 19 min
  • Podcast

Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

  • Résumé

  • Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    Voir plus Voir moins

Ce que les auditeurs disent de Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.